Blood RNA test study for new stroke patients
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial looks at certain molecules in the blood (called circRNA) in people who have a new ischemic stroke (a blockage in a blood vessel). It may help researchers understand what these blood signals mean soon after stroke, which could guide future treatments or monitoring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old
- Have a confirmed new ischemic stroke on brain scans (MRI and CT showing new affected areas)
- Be able to start screening within 72 hours after your symptoms began
- Be well enough to carry out study steps (good overall function)
- Have signed the study consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood tests to find signs of immune activity after a suspected stroke. It may help doctors diagnose stroke faster and better understand what is happening in the body soon after symptoms start.
This study looks at how the nervous system's automatic functions (like heart rate and blood pressure) change after a stroke. It uses MRI scans and blood tests to find patterns that might help doctors better understand and treat these changes.
This trial studies special molecules in the blood (non-coding RNA) in people having an acute ischemic stroke treated with a procedure to remove clots. It may help doctors better understand how the body responds and potentially improve future stroke care.
This trial looks at blood “RNA markers” (molecules that may reflect brain injury) in people who have had a new ischemic stroke. It may help doctors understand what’s happening in the body soon after stroke and possibly guide future care.
This study looks at RNA markers in the blood of people having their first heart attack to see if they can predict recovery. If you are scheduled for a procedure to open blocked arteries, you may be able to join.
This study is testing whether certain substances in your blood can help doctors better detect and understand problems with blood flow in the brain. Researchers hope these new 'biomarkers' could lead to faster and more accurate diagnosis of conditions like stroke and mini-stroke.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.